Spotlight On: Advanced Diagnostics and Therapeutics Catalyst Cluster Posted: Tuesday, November 12, 2024 Researchers are developing new tests and methods that could better diagnose and treat patients with different diseases, through our Advanced Diagnostics and Therapeutics Catalyst Cluster. Find out more about the impact of our cutting-edge research in the fourth film of our Spotlight On series. Continue reading full article: Spotlight On: Advanced Diagnostics and Therapeutics Catalyst Cluster
PhDs in Focus: Cancer of Unknown Primary – ‘The nameless cancer’ Posted: Friday, November 8, 2024 Author: Holly Cassell For our PhDs in Focus blog series, Holly Cassell outlines how their Manchester BRC PhD project aims to shed light on the identities of unknown cancers, within the Cancer Precision Medicine theme as part of work from a team at the Cancer Research UK National Biomarker Centre. Continue reading full article: PhDs in Focus: Cancer of Unknown Primary – ‘The nameless cancer’
PhDs in Focus: Understanding rare diseases Posted: Thursday, November 7, 2024 Author: Aoife O’Sullivan For our PhDs in Focus blog series, Aoife O’Sullivan outlines how their Manchester BRC PhD project is investigating how certain rare developmental genetic conditions affect a person’s thinking, behavioural, emotional and social skills, as part of the Rare Conditions theme. Continue reading full article: PhDs in Focus: Understanding rare diseases
Embed, Build, Accelerate – Manchester BRC Director’s blog – November 2024 Posted: Friday, November 1, 2024 Author: Professor Anne Barton In her latest blog Professor Anne Barton, Director of Manchester BRC, celebrates the £68.2 million in additional funding awards that we have leveraged in our second year and how they support our vast teams to deliver research which can save, change and improve lives. Continue reading full article: Embed, Build, Accelerate – Manchester BRC Director’s blog – November 2024
PhDs in Focus: The predictive value of extended high-frequency hearing Posted: Thursday, October 31, 2024 Author: Melanie Lough For our PhDs in Focus blog series, Melanie Lough outlines how their Manchester BRC PhD project aims to determine the value of the highest frequency range of human hearing for predicting hearing aid fitting outcomes, as part of our Hearing Health theme. Continue reading full article: PhDs in Focus: The predictive value of extended high-frequency hearing
Most non-cancer pain opioid prescriptions are for musculoskeletal conditions, study finds Posted: Monday, October 28, 2024 Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the drug’s efficacy, according to the largest UK study of its kind. Continue reading full article: Most non-cancer pain opioid prescriptions are for musculoskeletal conditions, study finds
PhDs in Focus: Understanding the risk of developing mental health conditions among children and young people after a cancer diagnosis Posted: Wednesday, October 9, 2024 Author: Moe Zandy For our PhDs in Focus blog series, Moe Zandy outlines how their Manchester BRC PhD project is investigating the risk of developing mental health conditions among children and young people who have been diagnosed with cancer, as part of the Living With and Beyond Cancer theme. Continue reading full article: PhDs in Focus: Understanding the risk of developing mental health conditions among children and young people after a cancer diagnosis
PhDs in Focus: Enhancing opioid safety – Predicting adverse outcomes in musculoskeletal and post-surgery patients Posted: Wednesday, October 9, 2024 Author: Christina Diomatari For our PhDs in Focus blog series, Christina Diomatari outlines how their Manchester BRC PhD project aims to improve the safety of opioid use for patients with musculoskeletal conditions and those recovering from orthopaedic surgery, as part of the Rheumatic and Musculoskeletal Diseases theme. Continue reading full article: PhDs in Focus: Enhancing opioid safety – Predicting adverse outcomes in musculoskeletal and post-surgery patients